Somaxon Pharmaceuticals prices public offering of common stock

Somaxon Pharmaceuticals, Inc., a US-based specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products, has priced an underwritten public offering of 8.8 million shares of its common stock at a price of $2.95 per share to raise gross proceeds of $25.96 million.
Somaxon has granted the underwriter a 30-day option to purchase up to 1.32 million additional shares of common stock to cover over-allotments, if any. The offering is expected to close on or about November 24, 2010.
Announcement (November 18, 2010):
Somaxon intends to offer its common stock in an underwritten public offering.
Piper Jaffray & Co. is acting as the sole underwriter for the offering.
Deal Value (US$ Million) 25.96

Deal Type IPO

Sub-Category Secondary Offering

Deal Status Announced: 2010-11-18

Deal Participants